![](https://european-biotechnology.com/wp-content/uploads/2024/04/eb_2019_sponsored_lumentus.jpg)
Whitepaper Spotlight: Proactive Biomarker Planning to Optimize Clinical Trials
Oncology drugs developed through a biomarker-guided precision medicine design are 38% more likely to be commercialized. But success relies on following a plan from the start -- learn how in this free whitepaper